Skip to main content Skip to page footer

Directorate of the NCT Heidelberg

The NCT Directorate Heidelberg runs the NCT Heidelberg and is responsible for the development and implementation of the strategic and operational measures. It consists of representatives of the research focuses at the German Cancer Research Center (DKFZ), the Medical Directors from the departments of Surgery, Hematological Oncology, Medical Oncology, Neurooncology, Pathology and Radiation Oncology at the Heidelberg University Hospital (UKHD) as well as representatives of the Thoraxklinik Heidelberg and representatives of the Patient Research Council.

The Managing Directorate of the NCT Heidelberg consists of the Managing Directors and the Head of Administration of the NCT Heidelberg.

Prof. Dr. Dr. Amir Abdollahi


Managing Director NCT Heidelberg

Translational Radiation Oncology, Heidelberg University Hospital (UKHD)
Heidelberg Ion-Beam Therapy Center, UKHD
Head: CCU Translational Radiation Oncology, German Cancer Research Center (DKFZ)
Chair: Translational Radiation Oncology (associated with the German Cancer Consortium, DKTK)

Prof. Dr. Stefan Fröhling


Managing Director NCT Heidelberg

Head of Division: Translational Medical Oncology, German Cancer Research Center (DKFZ)

Prof. Dr. Dirk Jäger


Managing Director NCT Heidelberg

Medical Director: Department of Medical Oncology, Heidelberg University Hospital (UKHD)
Head: CCU Applied Tumor-Immunity, German Cancer Research Center (DKFZ)

Prof. Dr. Peter Lichter


Managing Director NCT Heidelberg

Head of Division: Molecular Genetics, German Cancer Research Center (DKFZ)

Prof. Dr. Lena Maier-Hein


Managing Director NCT Heidelberg

Head of Division: Intelligent Medical Systems, German Cancer Research Center (DKFZ)

Prof. Dr. Dr. Eva Winkler


Managing Director NCT Heidelberg

Head: Section of Translational Medical Ethics; (formerly Ethics and Patient oriented Care in Oncology (NCT-EPOC)), Heidelberg University Hospital (UKHD)

Dr. Karolin Willmund


Head of Administration NCT Heidelberg

Phone: +49 6221 56-36458
Fax: +49 6221 56-6967
E-mail: karolin.willmund(at)nct-heidelberg.de

Together with the Managing Directorate of the NCT Heidelberg, the following members form the Extended Directorate of the NCT Heidelberg:

Prof. Dr. Hermann Brenner

Head: Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ)

Prof. Dr. Christoph Michalski

Medical Director: Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital

Prof. Dr. Carsten Müller-Tidow

Medical Director: Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital

PD Dr. Dr. Angelika Riemer

Head: Division of Immunotherapy and Immunoprevention, German Cancer Research Center (DKFZ)

Prof. Dr. Hans-Reimer Rodewald

Head: Division of Cellular Immunology, German Cancer Research Center (DKFZ)

Prof. Dr. Peter Schirmacher

Medical Director: General Pathology and Pathologic Anatomy, Heidelberg University Hospital

Prof. Dr. Dipl.-Phys. Heinz-Peter Schlemmer

Head: Division of Radiology
Coordinator: Research Program Imaging and Radiooncology, German Cancer Research Center (DKFZ)
 

Prof. Dr. Michael Thomas

Chief Physician: Department of Oncology of Thoracic Tumors, Thoraxklinik-Heidelberg at Heidelberg University Hospital

Prof. Dr. Andreas Trumpp

Head: Division of Stem Cells and Cancer,
Coordinator: Research Program Cell Biology and Tumor Biology, German Cancer Research Center (DKFZ)

Prof. Dr. Wolfgang Wick

Medical Director: Department of Neurology and Polyclinic, Heidelberg University Hospital
Head: CCU Neurooncology, German Cancer Research Center (DKFZ)

Representatives of the Patient Research Council

Imke Veit-Schirmer

Deputy Spokeswoman Patient Research Council NCT Heidelberg
Spokeswoman Patient Advisory Board NCT Heidelberg